Prevention and treatment of perioperative venous thromboembolism in patients with inguinal hernia

doi:10.3877/cma.j.issn.1674-392X.2023.04.006

Abstract

Abstract:

Venous thromboembolism (VTE) includes deep venous thrombosis (DVT) and pulmonary thromboembolism (PTE). It is one of the most common perioperative complications in surgical patients, resulting in a high mortality and disability rate and being one of the most important causes of unexpected death in hospitalized patients. VTE not only causes serious physical and mental damage to the patients, but also brings a serious economic burden to society. In recent years, VTE has attracted more and more attention in the medical field, and a series of guidelines for the diagnosis and treatment of VTE have been published. Although there are good programs for the prevention of VTE in orthopedics and general surgery, the management of perioperative VTE in patients with inguinal hernia is still not well understood or widely discussed. There are many perioperative VTE risk factors in patients with inguinal hernias. At present, there is a lack of accurate reports on the prevention and treatment of perioperative VTE in patients with inguinal hernias. Therefore, we summarize the domestic and foreign studies related to VTE to write this review in order to provide clinical reference for the prevention and treatment of perioperative VTE in patients with inguinal hernia.

Key words: Venous thromboembolism, Hernia, inguinal, Risk factors, Complication, Treatment

Jie Zhang, Ming Xie. Prevention and treatment of perioperative venous thromboembolism in patients with inguinal hernia[J]. Chinese Journal of Hernia and Abdominal Wall Surgery(Electronic Edition), 2023, 17(04): 394-399.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhshfbwkzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1674-392X.2023.04.006

https://zhshfbwkzz.cma-cmc.com.cn/EN/Y2023/V17/I04/394

References 50

[1]	Cushman M. Epidemiology and risk factors for venous thrombosis[J]. Semin Hematol, 2007, 44(2): 62-69.
[2]	Benjamin EJ, Blaha MJ, Chiuve SE, et al. Heart disease and stroke statistics-2017 update: A report from the American Heart Association[J]. Circulation, 2017, 135: e146-e603.
[3]	中华医学会呼吸病学分会肺栓塞与肺血管病学组, 中国医师协会呼吸医师分会肺栓塞与肺血管病工作委员会, 全国肺栓塞与肺血管病防治协作组. 肺血栓栓塞症诊治与预防指南[J]. 中华医学杂志, 2018, 98(14): 1060-1087.
[4]	Zhang Z, Lei J, Shao X, et al. Trends in hospitalization and inhospital mortality from VTE, 2007 to 2016, in China[J]. Chest, 2019, 155(2): 342353.
[5]	刘凤林, 秦净. 从指南到实践:解析《中国普通外科围手术期血栓预防与管理指南》[J]. 协和医学杂志, 2018, 9(2): 144-149.
[6]	Hill J, Treasure T. Reducing the risk of venous thromboembolism in patients admitted to hospital: summary of NICE guidance[J]. BMJ, 2010, 340: c95.
[7]	Falck-Ytter Y, Francis CW, Johanson NA, et al. Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed；American College of Chest Physicians Evidence-Based Clinical Practice Guidelines[J]. Chest, 2012, 141(2 Suppl): e278S-e325S.
[8]	Kumar DR, Hanlin E, Glurich I, et al．Virchow's contribution to the understanding of thrombosis and cellular biology[J]．Clin Med Res, 2010, 8(3/4): 168-172．
[9]	Kingsnorth A, LeBlanc K. Hernias: inguinal and incisional[J]. Lancet, 2003, 362(9395): 1561-1571.
[10]	Fitzgibbons RJ Jr. , Ramanan B, Arya S, et al. Long-term results of a randomized controlled trial of a nonoperative strategy(watchful waiting) for men with minimally symptomatic inguinal hernias[J]. Ann Surg, 2013, 258(3): 508-515.
[11]	Alhassan S, Pelinescu A, Gandhi V, et al. Clinical presentation and risk factors of venous thromboembolic disease[J]. Crit Care Nurs Q, 2017, 40(3): 201-209.
[12]	Liss D. Hypercoagulability and adrenal dysfunction in critical care[J]. Vet Technician, 2010, 31(8): E1-E3.
[13]	Lind C, Flinterman LE, Enga KF, et al. Impact of incident venous thromboembolism on risk of arterial thrombotic diseases[J]. Circulation, 2014, 129: 855-863.
[14]	Mulder FI, Horváth-Puhó E, van Es N, et al. Venous thromboembolism in cancer patients: a population-based cohort study[J]. Blood, 2021, 137(14): 1959-1969.
[15]	Falanga A, Schieppati F, Russo L. Pathophysiology 1. Mechanisms of thrombosis in cancer patients[J]. Cancer Treat Res, 2019, 179: 11-36.
[16]	Falanga A, Ay C, Di Nisio M, et al. Venous thromboembolism in cancer patients: ESMO Clinical Practice Guideline[J]. Ann Oncol, 2023, 34(5): 452-467.
[17]	Dong W, Zhu Y, Du Y, et al. Association between features of COPD and risk of venous thromboembolism[J]. Clin Respir J, 2019, 13(8): 499-504.
[18]	Milgrom A, Lee K, Rothschild M, et al. Thrombophilia in 153 Patients With Premature Cardiovascular Disease≤Age 45[J]. Clin Appl Thromb Hemost, 2018, 24(2): 295-302.
[19]	Wang M, Zhang G, Chen J, et al. Current prevalence of perioperative early venous thromboembolism and risk factors in Chinese adult patients with inguinal hernia(CHAT-1)[J]. Sci Rep, 2020, 10: 12667.
[20]	中华医学会外科学分会疝与腹壁外科学组, 中国医师协会外科医师分会疝和腹壁外科医师委员会. 成人腹股沟疝诊断和治疗指南(2018年版)[J/OL]. 中华疝和腹壁外科杂志(电子版), 2018, 12(4): 244-246.
[21]	Fleming FJ, Kim MJ, Salloum RM, et al. How much do we need to worry about venous thromboembolism after hospital discharge? A study of colorectal surgery patients using the National Surgical Quality Improvement Program database[J]. Dis Colon Rectum, 2010, 53: 1355-1360.
[22]	Rosenfeld BA, Beattie C, Christopherson R, et al. The effects of different anesthetic regimens on fibrinolysis and the development of postoperative arterial thrombosis. Perioperative Ischemia Randomized Anesthesia Trial Study Group[J]. Anesthesiology, 1993, 79(3): 435-443.
[23]	张杰, 张桃, 宁伟伟, 等．腹股沟疝术后发生静脉血栓栓塞症的影响因素分析[J]. 中华消化外科杂志, 2020, 19(7): 751-756.
[24]	Cohen AT, Tapson VF, Bergmann JF, et al. Venous thromboembolism risk and prophylaxis in the acute hospital care setting(ENDORSE study): a multinational cross-sectional study[J]. Lancet, 2008, 371(9610): 387-394.
[25]	Caprini JA. Thrombosis risk assessment as a guide to quality patient care[J]. Dis Mon, 2005, 51(2/3): 70-78.
[26]	Barbar S, Noventa F, Rossetto V, et al. A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score[J]. Thromb Haemost, 2010, 8(11): 2450-2457.
[27]	Autar R. Nursing assessment of clients at risk of deep vein thrombosis(DVT): the Autar DVT scale[J]. J Adv Nurs, 1996, 23: 763-770.
[28]	Kucher N, Koo S, Quiroz R, et al. Electronic alerts to prevent venous thromboembolism among hospitalized patients[J]. N Engl J Med, 2005, 352: 969-977.
[29]	Zhou HX, Peng LQ, Yan Y, et al. Validation of the Caprini risk assessment model in Chinese hospitalized patients with venous thromboembolism[J]. Thromb Res, 2012, 130(5): 735-740.
[30]	Gould MK, Garcia DA, Wren SM, et al. Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines[J]. Chest, 2012, 141(2 Suppl): e227S-e277S.
[31]	符伟国, 王利新. 围手术期静脉血栓栓塞疾病诊治争议与共识[J]. 中国实用外科杂志, 2015, 35(1): 66-68, 71.
[32]	Guanella R, Righini M. Serial limited versus single complete compression ultrasonography for the diagnosis of lower extremity deep vein thrombosis[J]. Semin Respir Crit Care Med, 2012, 33(2): 144-150.
[33]	Stein PD, Fowler SE, Goodman LR, et al. Multidetector computed tomography for acute pulmonary embolism[J]. N Engl J Med, 2006, 354(22): 2317-2327.
[34]	McRae SJ, Ginsberg JS. Update in the diagnosis of deep-vein thrombosis and pulmonary embolism[J]. Curr Opin Anaesthesiol, 2006, 19(1): 44-51.
[35]	Siniscalchi C. Protective role of statins during anticoagulation for venous thromboembolism: beyond their lipid lowering effect?[J]. Eur J Intern Med, 2020, 79: 127-129.
[36]	Ridker PM, Danielson E, Fonseca FA, et al. Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial[J]. Lancet, 2009, 373(9670): 1175-1182.
[37]	Mahmoodi BK, Cushman M, Anne Næss I, et al. Association of Traditional Cardiovascular Risk Factors With Venous Thromboembolism: An Individual Participant Data Meta-Analysis of Prospective Studies[J]. Circulation, 2017, 135(1): 7-16.
[38]	Zöller B, Li X, Sundquist J, et al. Socioeconomic and occupational risk factors for venous thromboembolism in Sweden: a nationwide epidemiological study[J]. Thromb Res, 2012, 129(5): 577-582.
[39]	Abdollahi M, Cushman M, Rosendaal FR. Obesity: risk of venous thrombosis and the interaction with coagulation factor levels and oral contraceptive use[J]. Thromb Haemost, 2003, 89(3): 493-498.
[40]	Roach RE, Lijfering WM, Flinterman LE, et al. Increased risk of CVD after VT is determined by common etiologic factors[J]. Blood, 2013, 121(24): 4948-4954.
[41]	Kearon C, Akl EA, Ornelas J, et al. Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report[J]. Chest, 2016, 149(2): 315-352.
[42]	Mazzolai L, Aboyans V, Ageno W, et al. Diagnosis and management of acute deep vein thrombosis: a joint consensus document from the European Society of Cardiology working groups of aorta and peripheral vascular diseases and pulmonary circulation and right ventricular function[J]. Eur Heart J, 2018, 39(47): 4208-4218.
[43]	Schindewolf M, Weitz JI. Broadening the Categories of Patients Eligible for Extended Venous Thromboembolism Treatment[J]. Thromb Haemost, 2020, 120(1): 14-26.
[44]	Baker PM, Keeling DM. A single dose of Low-molecular-weight Heparin(LMWH) invalidates the use of D-dimer as part of a Deep Vein Thrombosis(DVT) diagnostic algorithm[J]. Int J Lab Hematol, 2017, 39(1): e17-e18.
[45]	De Athayde Soares R, Matielo MF, Brochado Neto FC, et al. Reply to: On the questionable ethics of randomizing patients with acute DVT to receive rivaroxaban or warfarin[J]. Surgery, 2020, 167(2): 515-516.
[46]	Amin A, Marrs JC. Direct Oral Anticoagulants for the Management of Thromboembolic Disorders: The Importance of Adherence and Persistence in Achieving Beneficial Outcomes[J]. Clin Appl Thromb Hemost, 2016, 22(7): 605-616.
[47]	吴丹明, 张立魁. 腹部外科围手术期下肢深静脉血栓的预防与治疗[J]. 中国实用外科杂志, 2015, 35(12): 1285-1289.
[48]	刘坚军, 董智慧, 符伟国. 普通外科围手术期静脉血栓栓塞症防治中血管外科干预原则与策略[J]. 中国实用外科杂志, 2020, 40(5): 515-519.
[49]	Kearon C, Akl EA, Comerota AJ, et al. Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines[J]. Chest, 2012, 141(2 Suppl): e419S-e496S.
[50]	Brunson A, Ho G, White R, et al. Inferior vena cava filters in patients with cancer and venous thromboembolism(VTE) does not improve clinical outcomes: A population-based study[J]. Thromb Res, 2017, 153(1): 57-64.

Please choose a citation manager

Content to export